Record Orders for MiSeq, Consumables Drive Illumina's Q1 Sequencing Revenues | GenomeWeb

Sales of Illumina's MiSeq benchtop sequencer and sequencing consumables drove double-digit percent sequential revenue growth in the company's sequencing business for the first quarter of 2012, the company reported this week.

In the first quarter, Illumina "had record orders for both the MiSeq instrument and sequencing consumables," chief financial officer Marc Stapley said during a conference call to discuss the company's first quarter earnings.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.